Coronavirus pandemic: daily updated research and data.
Read more
Our work belongs to everyone
Cite our vaccination data
Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)

Our vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there.

In our Data Explorer you can see all of our data on COVID-19 vaccinations (doses administered, people with at least 1 dose, and people fully vaccinated).

Open the Data Explorer in a new tab.

Select a group of countries at once: all European countries, 30 largest countries; EU; Americas; OECD.


The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the COVID-19 pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2, the virus that causes COVID-19.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international COVID-19 vaccination dataset that we make available on this page. It is updated each morning, with the most recent official numbers up to the previous day.

  • Open access: as with all of our data, we are making this dataset openly available, so that everyone can check and use the data that we bring together. You find the vaccination data in our daily-updated repository on GitHub.

Country-by-country data on COVID-19 vaccinations

This page has a number of charts on vaccination. In the box below you can select any country you are interested in — or several, if you want to compare countries.

All charts on this page will then show data for the countries that you selected.

None selected

What share of the population has been partly or fully vaccinated against COVID-19?

The following charts show the breakdown of vaccinations by those that have been partly or fully vaccinated. A person is considered partly vaccinated if they have received only one dose of a 2-dose vaccine protocol. A person is considered fully vaccinated if they have received a single-dose vaccine or both doses of a two-dose vaccine.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

How many COVID-19 vaccine doses are administered daily?

Daily number of COVID-19 vaccinations administered per 100 people

The following chart shows the daily number of COVID-19 vaccination doses administered per 100 people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of COVID-19 vaccinations administered

How many COVID-19 vaccination doses have been administered?

The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime as several available COVID vaccines require multiple doses.

Total number of COVID-19 vaccinations administered

The following chart shows the total number of COVID-19 vaccination doses administered. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

What share of the population has received at least one dose of the COVID-19 vaccine?

The following chart shows the share of the total population that has received at least one dose of the COVID-19 vaccine. This may not equal the share that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

Total number of people who have received at least one dose of the COVID-19 vaccine

The following chart shows the total number of people that have received at least one dose of the COVID-19 vaccine. This may not equal the number that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

What share of the population has been fully vaccinated against COVID-19?

The following chart shows the share of the total population that has been fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Total number of people who have been fully vaccinated against COVID-19

The following chart shows the total number of people that have been fully vaccinated against COVID-19. This represents the number that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Which vaccines have been administered in each country?

The following chart shows the cumulative number of doses administered, broken down by vaccine manufacturer.

This is only available for a select number of countries which report the necessary data.

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Attitudes to COVID-19 vaccinations

The Imperial College London YouGov Covid-19 Behaviour Tracker Data Hub gathers global insights on people’s behaviors in response to COVID-19. This survey covers public behaviors and attitudes ranging from mask-wearing to self-isolation, social distancing, symptoms and testing.

The following two charts show monthly data from this survey on the willingness of people to get vaccinated against COVID-19. Survey respondents were presented with the following statement: “If a COVID-19 vaccine were made available to me this week, I would definitely get it.” Respondents were asked to react to this statement on a 1 to 5 scale, ranging from “Strongly agree” (1) to “Strongly disagree” (5).

Based on this scale, we consider respondents to be willing to get a COVID-19 vaccine if they selected 1 or 2, unwilling to get a COVID-19 vaccine if they selected 4 or 5, and uncertain if they are willing to get a COVID-19 vaccine if they selected 3.

Both charts below show the share of a country’s population that has received at least one dose of a COVID-19 vaccine in comparison to the share of the population that is unvaccinated, where the share of the unvaccinated population is separated into those who would be willing vs. unwilling vs. uncertain if they would get a COVID-19 vaccine if it was made available to them this week.1

The first chart shows this data for a single country over time, while the second chart shows the same data for multiple countries at a single point in time.

Vaccine development: vaccines approved for use and in clinical trials

The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which we’ve known the pathogens for more than a century (like malaria) we still haven’t found an effective vaccine.

The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries. 

The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.

We are on the way to several vaccines against COVID-19 – vaccine trackers monitor the progress:

Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed:

Source information country by country

You can download the full dataset alongside the detailed sources on GitHub.

Vaccination against COVID-19 has now started in 206 locations.

LocationSourceLast observation dateVaccines
AfghanistanWorld Health OrganizationMay. 11, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
AlbaniaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
AlgeriaMinistry of HealthFeb. 19, 2021Sputnik V
AndorraGovernment of AndorraMay. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech
AngolaWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca
AnguillaMinistry of HealthApr. 22, 2021Oxford/AstraZeneca
Antigua and BarbudaMinistry of HealthMay. 11, 2021Oxford/AstraZeneca
ArgentinaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
ArmeniaMinistry of HealthMay. 11, 2021Sputnik V
ArubaGovernment of ArubaMay. 14, 2021Pfizer/BioNTech
AustraliaGovernment of Australia via covidlive.com.auMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech
AustriaMinistry of HealthMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AzerbaijanGovernment of AzerbaijanMay. 14, 2021Oxford/AstraZeneca, Sinovac
BahamasGovernment of the BahamasMay. 9, 2021Oxford/AstraZeneca
BahrainMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
BangladeshDirectorate General of Health ServicesMay. 12, 2021Oxford/AstraZeneca
BarbadosMinistry of HealthMay. 13, 2021Oxford/AstraZeneca
BelarusMinistry of HealthApr. 23, 2021Sputnik V
BelgiumSciensanoMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
BelizeMinistry of HealthMay. 12, 2021Oxford/AstraZeneca
BeninWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca, Sinovac
BermudaGovernment of BermudaMay. 12, 2021Pfizer/BioNTech
BhutanMinistry of HealthMay. 13, 2021Oxford/AstraZeneca
BoliviaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
Bonaire Sint Eustatius and SabaWorld Health OrganizationApr. 9, 2021Moderna, Pfizer/BioNTech
Bosnia and HerzegovinaPublic Health InstituteApr. 27, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BotswanaMinistry of Health and WellnessMay. 7, 2021Oxford/AstraZeneca
BrazilMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BruneiMinistry of HealthMay. 5, 2021Oxford/AstraZeneca
BulgariaMinistry of HealthMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CambodiaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
CameroonMedical CouncilApr. 29, 2021Sinopharm/Beijing
CanadaOfficial data from provinces via covid19tracker.caMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Cape VerdeWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Cayman IslandsCayman Islands GovernmentMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Central African RepublicWorld Health OrganizationMay. 12, 2021Covaxin, Oxford/AstraZeneca
ChileDepartment of Statistics and Health InformationMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ChinaNational Health CommissionMay. 14, 2021Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac
ColombiaMinistry of HealthMay. 13, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ComorosWorld Health OrganizationMay. 12, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
CongoWorld Health OrganizationMay. 12, 2021Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Costa RicaCosta Rican Social Security FundMay. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Cote d’IvoireMinistry of Health and Public HygieneMay. 13, 2021Oxford/AstraZeneca
CroatiaMinistry of HealthMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CubaMinistry of HealthMay. 12, 2021Abdala
CuracaoGovernment of CuracaoMay. 14, 2021Moderna, Pfizer/BioNTech
CyprusMinistry of HealthMay. 14, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
CzechiaMinistry of HealthMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Democratic Republic of CongoMinistry of HealthApr. 25, 2021Oxford/AstraZeneca
DenmarkStatens Serum InstituteMay. 13, 2021Moderna, Pfizer/BioNTech
DjiboutiWorld Health OrganizationApr. 28, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
DominicaGovernment of DominicaMay. 12, 2021Oxford/AstraZeneca
Dominican RepublicMinistry of Public HealthMay. 13, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
EcuadorGovernment of Ecuador via EcuacovidMay. 13, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EgyptWorld Health OrganizationMay. 11, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
El SalvadorMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EnglandGovernment of the United KingdomMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Equatorial GuineaMinistry of HealthApr. 28, 2021Sinopharm/Beijing
EstoniaNational Health BoardMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
EswatiniGovernment of EswatiniMay. 13, 2021Oxford/AstraZeneca
EthiopiaMinistry of HealthMay. 13, 2021Oxford/AstraZeneca
Faeroe IslandsGovernment of the Faeroe IslandsMay. 13, 2021Moderna, Pfizer/BioNTech
Falkland IslandsGovernment of the Falkland IslandsApr. 14, 2021Oxford/AstraZeneca
FijiSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
FinlandFinnish Institute for Health and WelfareMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FrancePublic Health FranceMay. 13, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
French PolynesiaSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
GabonMinistry of HealthApr. 30, 2021Sinopharm/Beijing
GambiaMinistry of HealthMay. 6, 2021Oxford/AstraZeneca
GeorgiaGovernment of GeorgiaMay. 14, 2021Oxford/AstraZeneca
GermanyRobert Koch InstitutMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GhanaGovernment of GhanaMay. 7, 2021Oxford/AstraZeneca
GibraltarGovernment of GibraltarMay. 14, 2021Pfizer/BioNTech
GreeceMinistry of HealthMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GreenlandGovernment of GreenlandMay. 14, 2021Pfizer/BioNTech
GrenadaGovernment of GrenadaMay. 11, 2021Oxford/AstraZeneca
GuatemalaMinistry of HealthMay. 13, 2021Moderna, Oxford/AstraZeneca
GuernseyGovernment of GuernseyMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GuineaNational Health Security AgencyMay. 12, 2021Sputnik V
Guinea-BissauWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca, Sinopharm/Beijing
GuyanaMinistry of HealthMay. 6, 2021Oxford/AstraZeneca
HondurasGovernment of HondurasApr. 9, 2021Moderna, Oxford/AstraZeneca
Hong KongGovernment of Hong KongMay. 14, 2021Pfizer/BioNTech, Sinovac
HungaryGovernment of HungaryMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IcelandDirectorate of HealthMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
IndiaGovernment of IndiaMay. 14, 2021Covaxin, Oxford/AstraZeneca
IndonesiaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Sinovac
IranWorld Health OrganizationMay. 10, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
IraqMinistry of HealthMay. 11, 2021Oxford/AstraZeneca, Sinopharm/Beijing
IrelandHeath Service ExecutiveMay. 11, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Isle of ManIsle of Man GovernmentMay. 12, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Israel (see FAQ)Government of IsraelMay. 14, 2021Moderna, Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JamaicaGovernment of JamaicaApr. 13, 2021Oxford/AstraZeneca
JapanPrime Minister’s OfficeMay. 13, 2021Pfizer/BioNTech
JerseyGovernment of JerseyMay. 13, 2021Oxford/AstraZeneca, Pfizer/BioNTech
JordanGovernment of JordanMay. 4, 2021Pfizer/BioNTech, Sinopharm/Beijing
KazakhstanGovernment of KazakhstanMay. 14, 2021Sputnik V
KenyaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Sputnik V
KosovoMinistry of HealthApr. 23, 2021Oxford/AstraZeneca
KuwaitMinistry of HealthMay. 6, 2021Pfizer/BioNTech
KyrgyzstanMinistry of HealthMay. 11, 2021Sinopharm/Beijing, Sputnik V
LaosGovernment of LaosMay. 13, 2021Sinopharm/Beijing, Sputnik V
LatviaNational Health ServiceMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LebanonGovernment of LebanonMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
LesothoWorld Health OrganizationApr. 17, 2021Oxford/AstraZeneca
LiberiaWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca
LibyaWorld Health OrganizationMay. 10, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
LiechtensteinFederal Office of Public HealthMay. 12, 2021Moderna, Pfizer/BioNTech
LithuaniaMinistry of HealthMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LuxembourgGovernment of LuxembourgMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MacaoGovernment of MacaoMay. 14, 2021Pfizer/BioNTech, Sinopharm/Beijing
MadagascarWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca
MalawiMinistry of HealthMay. 13, 2021Oxford/AstraZeneca
MalaysiaGovernment of MalaysiaMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
MaldivesPresidency of the MaldivesMay. 13, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
MaliMinistry of HealthApr. 25, 2021Oxford/AstraZeneca
MaltaCOVID-19 Malta Public Health Response TeamMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MauritaniaMinistry of HealthApr. 18, 2021Sinopharm/Beijing
MauritiusWorld Health OrganizationMay. 12, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
MexicoSecretary of HealthMay. 13, 2021CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
MoldovaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MonacoNational CouncilMay. 6, 2021Pfizer/BioNTech
MongoliaMinistry of Health via ikon.mnMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontenegroGovernment of MontenegroMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontserratGovernment of MontserratApr. 21, 2021Oxford/AstraZeneca
MoroccoMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Sinopharm/Beijing
MozambiqueWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca, Sinopharm/Beijing
MyanmarMinistry of HealthMay. 4, 2021Oxford/AstraZeneca
NamibiaMinistry of Health and Social ServicesMay. 14, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NauruSPC Public Health DivisionApr. 30, 2021Oxford/AstraZeneca
NepalGovernment of NepalMay. 7, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NetherlandsRIVM via European CDCMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
New CaledoniaSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
New ZealandMinistry of HealthMay. 11, 2021Pfizer/BioNTech
NicaraguaWorld Health OrganizationMay. 7, 2021Oxford/AstraZeneca, Sputnik V
NigerWorld Health OrganizationMay. 12, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NigeriaGovernment of NigeriaMay. 14, 2021Oxford/AstraZeneca
North MacedoniaGovernment of North MacedoniaMay. 12, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
Northern CyprusMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Northern IrelandGovernment of the United KingdomMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
OmanMinistry of HealthMay. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
PakistanNational Command and Operation CentreMay. 13, 2021CanSino, Sinopharm/Beijing, Sinovac, Sputnik V
Palestine (see FAQ)Ministry of HealthMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PanamaMinistry of HealthMay. 12, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Papua New GuineaSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
ParaguayGovernment of ParaguayMay. 10, 2021Sputnik V
PeruMinistry of HealthMay. 13, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
PhilippinesGovernment of the PhilippinesMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
PolandMinistry of HealthMay. 14, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PortugalDirectorate General for Health via Data Science for Social GoodMay. 14, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
QatarMinistry of Public HealthMay. 14, 2021Pfizer/BioNTech
RomaniaGovernment of RomaniaMay. 13, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
RussiaOfficial data from local governments via gogov.ruMay. 14, 2021EpiVacCorona, Sputnik V
RwandaMinistry of HealthMay. 7, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Saint HelenaGovernment of Saint HelenaApr. 24, 2021Oxford/AstraZeneca
Saint Kitts and NevisGovernment of Saint Kitts and NevisMay. 12, 2021Oxford/AstraZeneca
Saint LuciaMinistry of HealthMay. 14, 2021Oxford/AstraZeneca
Saint Vincent and the GrenadinesMinistry of HealthMay. 12, 2021Oxford/AstraZeneca
SamoaSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
San MarinoSocial Security InstituteMay. 13, 2021Pfizer/BioNTech, Sputnik V
Sao Tome and PrincipeMinistry of HealthMar. 29, 2021Oxford/AstraZeneca
Saudi ArabiaSaudi Health CouncilMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech
ScotlandGovernment of the United KingdomMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SenegalMinistry of HealthMay. 13, 2021Sinopharm/Beijing
SerbiaGovernment of SerbiaMay. 12, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SeychellesExtended Programme for ImmunisationMay. 12, 2021Oxford/AstraZeneca, Sinopharm/Beijing
Sierra LeoneMinistry of Health and SanitationMay. 8, 2021Oxford/AstraZeneca
SingaporeMinistry of HealthMay. 13, 2021Moderna, Pfizer/BioNTech
Sint Maarten (Dutch part)World Health OrganizationMay. 7, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SlovakiaMinistry of HealthMay. 12, 2021Pfizer/BioNTech
SloveniaNational Institute of Public Health via SledilnikMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Solomon IslandsSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
SomaliaWorld Health OrganizationMay. 2, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
South AfricaMinistry of HealthMay. 14, 2021Johnson&Johnson
South KoreaKorea Centers for Disease Control and PreventionMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech
South SudanGovernment of South SudanApr. 15, 2021Oxford/AstraZeneca
SpainMinistry of HealthMay. 13, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Sri LankaMinistry of Health’s Epidemiology UnitMay. 14, 2021Oxford/AstraZeneca, Sinopharm/Beijing
SudanFederal Ministry of HealthApr. 23, 2021Oxford/AstraZeneca
SurinameGovernment of SurinameMay. 13, 2021Oxford/AstraZeneca
SwedenPublic Health Agency of SwedenMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech
SwitzerlandFederal Office of Public HealthMay. 12, 2021Moderna, Pfizer/BioNTech
SyriaMinistry of HealthApr. 8, 2021Sputnik V
TaiwanTaiwan Centers for Disease ControlMay. 14, 2021Oxford/AstraZeneca
TajikistanWorld Health OrganizationMay. 9, 2021Oxford/AstraZeneca
ThailandGovernment of ThailandMay. 13, 2021Oxford/AstraZeneca, Sinovac
TimorWorld Health OrganizationMay. 3, 2021Oxford/AstraZeneca
TogoGovernment of TogoApr. 17, 2021Oxford/AstraZeneca
TongaSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
Trinidad and TobagoMinistry of HealthMay. 14, 2021Oxford/AstraZeneca
TunisiaMinistry of HealthMay. 10, 2021Pfizer/BioNTech, Sinovac, Sputnik V
TurkeyCOVID-19 Vaccine Information PlatformMay. 14, 2021Pfizer/BioNTech, Sinovac
TurkmenistanWorld Health OrganizationApr. 4, 2021EpiVacCorona, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Turks and Caicos IslandsMinistry of HealthApr. 11, 2021Pfizer/BioNTech
TuvaluSPC Public Health DivisionApr. 27, 2021Oxford/AstraZeneca
UgandaMinistry of HealthMay. 12, 2021Oxford/AstraZeneca
UkraineMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V
United KingdomGovernment of the United KingdomMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionMay. 14, 2021Johnson&Johnson, Moderna, Pfizer/BioNTech
UruguayMinistry of HealthMay. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UzbekistanGovernment of UzbekistanMay. 11, 2021Oxford/AstraZeneca
VenezuelaGovernment of VenezuelaApr. 12, 2021Sputnik V
VietnamGovernment of VietnamMay. 11, 2021Oxford/AstraZeneca
WalesGovernment of the United KingdomMay. 13, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Wallis and FutunaSPC Public Health DivisionMay. 11, 2021Oxford/AstraZeneca
YemenWorld Health OrganizationMay. 9, 2021Oxford/AstraZeneca
ZambiaGovernment of ZambiaMay. 13, 2021Oxford/AstraZeneca
ZimbabweMinistry of HealthMay. 14, 2021Sinopharm/Beijing

Frequently-asked questions

Which population data are the per-capita metrics based on?

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. The exact values can be viewed in our GitHub repository. The United Nations estimates may not always reflect the latest censuses or national figures.

Can the value of per-capita metrics exceed 100%?

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects.  The United Nations estimates may not always reflect the latest censuses or national figures. Additionally, it’s important to bear in mind that in some territories, vaccination coverage may include non-residents (such as tourists and foreign workers). For these reasons, per-capita metrics may sometimes exceed 100%.

My country has started vaccinating its population. Why is it missing from the charts?

Other countries that are not shown in our data may have also started vaccination campaigns. We’ll add them to our maps and charts as soon as numbers are verifiable based on public official sources. If you’re aware of an official source reporting numbers, please let us know using the “Feedback” button at the bottom of your screen.

Are participants in vaccine clinical trials included in your data?

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

How do you report vaccinations performed in Israel and Palestine?

In our dataset and charts on COVID-19 vaccinations, we report vaccinations performed in Israel and Palestine separately.

The vaccination data is needed to understand how the pandemic is evolving. For this it is key to bring together the vaccination data with data on COVID-19 cases and COVID-19 deaths. Global health institutions that report on the pandemic are reporting these metrics separately: 

  • The World Health Organization reports the measures for Israel separately from Palestine in its data.
  • Johns Hopkins University also reports Israel separately from Palestine in its data on cases & deaths of COVID-19, which has been used worldwide in the last year.

Reporting the data for Palestine and Israel separately also allows us to show their respective reported vaccination levels. It makes clear what the respective vaccination levels are, as reported by the Government of Israel and the Palestinian Ministry of Health.

Finally, our dataset on COVID-19 vaccinations is sourced from official data published by governments and ministries of health from countries around the world. This is also the case for Israel and Palestine. We show figures for Palestine and Israel separately, as they are reported separately by the Government of Israel and the Palestinian Ministry of Health

The Populations Division of the United Nations reports population figures for countries around the world, and we are relying on their latest data (from their 2019 revision) for countries around the world of. They report a population of 8,655,541 people for Israel and a population of 5,101,416 people for Palestine.

The resulting shares of people vaccinated in Israel and Palestine can be seen in our COVID-19 Data Explorer.


Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with on our work on COVID-19, and the many other topics we cover you can sign up to our newsletter.